Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Where's the real news?

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Aug 21, 2024 2:40pm

213 Views

Post# 36190399

RE:RE:RE:RE:RE:RE:RE:Where's the real news?

Competition is CGON. CG0007. Many more treatments good results, Cannot be used on immune compromised patients( a big chunk). Storage can be an issue. Once they stop treating we don't yet know how fast CR numbers drop long term. Only short term numbers! We are a way better option, but the FDA and med community need many options as no one solution works 100% for all. Perhaps Rutherin come with Ruvidar for hard to treat cases may get us close to 100%?

<< Previous

Bullboard Posts

Next >>

IAMGOLD's Nelligan shows potential for expansion